Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Amy Trammell

Orthopaedic Surgery Charlotte, NC Medical Doctor

NPI 1730613761 CMS profile 11300390

10660 Park Rd, Ste 3100, Charlotte, NC 28210

Open in the dashboard

General payments

$14,037

90 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amy Trammell of Charlotte, NC is reported in the CMS Open Payments database as having received $14,037 across 90 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,254 34
2024 General $6,121 43
2023 General $3,460 10
2022 General $131 2
2021 General $72 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Trammell
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Amy Trammell were reported at $4,254. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Amy Trammell Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $72 $520 $117–$2,495 $132
2022 $131 $598 $128–$2,731 $149
2023 $3,460 $461 $128–$2,264 $160
2024 $6,121 $497 $134–$2,475 $164
2025 $4,254 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. TriMed, Inc. $5,460 20 payments
  2. Peerless Surgical Inc. $2,160 20 payments
  3. Acumed LLC $1,769 5 payments
  4. Arthrex, Inc. $1,519 14 payments
  5. Medical Device Business Services, Inc. $1,400 1 payment
  6. Skeletal Dynamics Inc $334 4 payments
  7. Stryker Corporation $319 7 payments
  8. Sanara MedTech Inc. $276 3 payments
  9. Exactech, Inc. $167 1 payment
  10. Davol Inc. $136 1 payment
  11. Other $498 14 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $7,201 16 payments
  2. Food and Beverage $5,736 72 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $1,000 1 payment
  4. Gift $100 1 payment
Products named General payments · program years 2021–2025
  1. Tools - WFS $3,611 16 payments
  2. ACUMED $1,769 5 payments
  3. INnate Implant $1,230 4 payments
  4. InFrame Implant $1,230 4 payments
  5. Geminus $334 4 payments
  6. Align $334 4 payments
  7. IJS $334 4 payments
  8. IMPlate $334 4 payments
  9. CellerateRx $276 3 payments
  10. Equinoxe $167 1 payment
  11. Other $1,612 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

373

Median for Orthopedic Surgery: 203

Drug cost

$2,111

Median for Orthopedic Surgery: $1,433

Branded share of claims

16.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 51 $552
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 45 $307
Amitriptyline Hcl Generic 26 $301
Methylprednisolone Generic 30 $196
Meloxicam Generic 73 $186
Tramadol Hcl Generic 82 $164
Cephalexin Generic 15 $158
Oxycodone Hcl Generic 33 $128
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $118

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 107 billing codes

Paid by Medicare

$135,247

Of which drugs: $516

Medicare patients

383

Average age 74

Services billed

1,872

229 women, 154 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 56%
Diabetes 26%
Ischemic heart disease 25%
Depression 24%
Chronic kidney disease 22%
Osteoporosis 17%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 140 692 $516

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

90 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record